An anti-fungal drug developed at the University of Arizona, now on a fast track for approval, could cure one of the most commonly reported infectious diseases in the state. Through Dec. 6, 5,310 cases ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Immunosuppressive therapy led to normalization of hematologic parameters and resolution of fever. Long-term use of propylthiouracil (PTU) may precipitate antineutrophil cytoplasmic antibody ...

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a T-cell–mediated severe cutaneous adverse reaction characterized by rash, fever, internal organ involvement, and systemic ...

Expert Rev Anti Infect Ther. 2013;11(8):805-815. Infectious diseases are the leading cause of FUO in almost all series (Table 2). Among infections, tuberculosis is the most frequent diagnosis. In ...

South Korea's Hyundai Bioscience said Friday it has joined a global clinical trial in Vietnam for dengue fever, a ...

In this interview, Dr Joseph Okoeguale, Director, Institute of Viral and Emergent Pathogens, Control and Research, Irrua Specialist Teaching Hospital (ISTH), Edo State, a leading centre for Lassa ...